Fred launches third-party apps market for pharmacies
Australian pharmacy IT options supplier Fred IT Group has launched an internet market of third-party purposes for pharmacies.
Referred to as Fred Market, the web-based hub has options which were authorized and examined to be used with Fred’s software program, together with apps and integrations for robots, eCommerce, enterprise intelligence, scientific providers, drug info and medicine administration, loyalty and cost.
Third-party options come from Fred’s trusted vendor companions, particularly BD, Dataology, GuildLink, LifeSmart, MIMs, Modeus, Storbie, StrongRoom, Tyro, and Willach Pharmacy Options.
{The marketplace} will proceed to carry on new software program companions and authorized purposes because it expands.
College of South Australia researchers develop fibre sensors to remotely monitor sufferers
Scientists from the College of South Australia have developed tiny optical fibre sensors to remotely observe the positions of sufferers coping with painful stress sores in their beds.
“Annually, hundreds of older Australians in hospitals and nursing properties expertise stress accidents, or ulcers, which take a very long time to heal and will be deadly. On the very least, these accidents could cause extreme ache, disrupt sleep, have an effect on their temper, in addition to their rehabilitation, mobility and high quality of life,” mentioned Dr Stephen Warren-Smith, the lead researcher behind the brand new know-how.
The fibre sensors are connected to the higher floor of a mattress to observe motion and document coronary heart and respiratory charges.
By choosing up their respiration, the unobtrusive sensors can detect when a affected person turns over, leaves a mattress, or stays immobile. Nurses will be prompted if a affected person has not moved for hours so they may modify their place.
Present strategies to observe sufferers coping with stress sores use weight-based sensors, which can’t predict when a affected person leaves the mattress till their toes contact the ground. Digital camera-based applied sciences are additionally getting used, though privateness is a significant concern.
EpiAxis Therapeutics, Peptilogics associate for AI drug discovery
Australian drug developer EpiAxis Therapeutics and Peptilogics, a US-based biotechnology firm, will harness AI in drug discovery to inhibit epigenetic oncology targets.
Their challenge will make use of Peptilogics’ AI platform Nautilus, along with EpiAxis’s experience in epigenetics, to advance drug discovery for cancers that escape present therapies via epigenetic change, together with metastatic breast most cancers.
“We are going to concentrate on lead optimisation utilizing Peptilogics’ Nautilus platform, which mixes proprietary deep generative fashions, predictive fashions, and biophysical simulation to design multiparameter-optimised peptides with [the] potential to handle traditionally difficult and novel drug targets,” mentioned Peptilogics CTO Nicholas Nystrom.
This partnership follows EpiAxis’s lately concluded scientific trial which for the primary time has used an epigenetic inhibitor alongside chemotherapy to deal with metastatic most cancers.
